AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

Survivin is an apoptosis antagonist.(Brief Article)

Women's Health Weekly

| March 13, 2003 | COPYRIGHT 2003 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2003 MAR 13 - (NewsRx.com & NewsRx.net) -- Survivin is an apoptosis antagonist.

According to recent research from Japan, "survivin, a protein that inhibits apoptosis, is expressed in a variety of tumor cells."

"We detected survivin-specific mRNA and protein in normal placental tissues, two human choriocarcinoma cell lines (JEG-3 and BeWo), and a trophoblastic cell line (tPA30-1) by reverse transcription-polymerase chain reaction (RT-PCR), Northern blotting, and Western blotting," described A. Shiozaki and colleagues, Toyama Med & Pharmaceutical University, Department Obstetrics & Gynecology.

"Immunohistochemically, survivin was localized to normal villous cytotrophoblasts, normal extravillous trophoblasts, cytotrophoblasts in hydatidiform mole, and choriocarcinoma cells."

"Antisense oligonucleotides for survivin dose-dependently induced apoptosis in two choriocarcinoma cell lines (JEG-3 and BeWo) and a trophoblastic ...

Related articles from newspapers, magazines, journals, and more
Survivin is an apoptosis antagonist.
Newspaper article from: Cancer Weekly March 11, 2003 700+ words
...and colleagues, Toyama Med & Pharmaceutical University, Department Obstetrics & Gynecology...contact S. Saito, Toyama Med & Pharmaceutical University, Department Obstetrics & Gynecology...
PBMC-influenced interleukin levels differ in normal vs. preeclamptic pregnancy.
Newspaper article from: Health & Medicine Week June 28, 2004 700+ words
...Immunol, 2004;61(2):133-143). For additional information, contact S. Saito, Toyama Med & Pharmaceutical University, Department Obstetrics & Gynecology, 2630 Sugitani, Sugitani, Toyama 9300194, Japan. The publisher...
A Recombinant BCG Vaccine for HIV-1 Protects Cynomolgus Monkeys from SHIVMN...
Newspaper article from: Vaccine Weekly August 10, 1998 700+ words
...AIDS Research Center, NIID, Tokyo; Div. Experimental Animal Research NIID, Tokyo; Biosafety Control NIID, Tokyo; Toyama Med. Pharma. University, Tokyo; Toyam Prefectual Health Institute, Toyama, Japan. According to an abstract submitted by...
Scopadulciol-related molecules are weak mediators of cancer gene therapy.
Newspaper article from: Cancer Weekly October 19, 2004 700+ words
...HeLa cells. Chem Pharm Bull Tokyo, 2004;52(8):1015-1017). For additional information, contact T. Hayashi, Toyama Med & Pharmaceutical University, Faculty Pharmaceutical Science, 2630 Sugitani, Toyama 9300194, Japan. Publisher contact...
Improved 1-h rapid immunostaining method uses intermittent microwave...
Newspaper article from: Science Letter November 2, 2004 700+ words
...University Hospital. Modern Pathol, 2004;17(9):1141-1149). For additional information, contact K. Tsuneyama, Toyama Med & Pharmaceutical University, Faculty Med, Department Pathology, 2630 Sugitani, Toyama 9300194, Japan. The publisher...
Th1 profile in preeclampsia is related to inflammation and poor placentation.
Magazine article from: Women's Health Weekly October 30, 2003 700+ words
...balance in preeclampsia. J Reprod Immunol, 2003;59(2):161-173). For additional information, contact S. Saito, Toyama Med & Pharmaceutical University, Dept Obstetrics & Gynecology, 2630 Sugitani, Toyama 9300194, Japan. Publisher...
Heterozygotic mothers of Wiskott-Aldrich syndrome children express WASP fully.
Newspaper article from: Health & Medicine Week October 6, 2003 700+ words
...Wiskott-Aldrich syndrome. Int J Hematol, 2003;78(1):40-44). For additional information, contact H. Kanegane, Toyama Med & Pharmaceutical University, Faculty Med, Dept Pediatrics, 2630 Sugitani, Toyama 9300194, Japan. The publisher...
Cyclooxygenase-2 is a prognostic indicator of oral squamous cell carcinoma.
Newspaper article from: Health & Medicine Week January 5, 2004 700+ words
...as a prognostic predictor. Oral Oncol, 2003;39(8):829-835). For additional information, contact K. Matsui, Toyama Med & Pharmaceutical University, Faculty Med, Department Pathology, 2630 Sugitani, Toyama 9300194, Japan. The publisher...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA